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Fungal pathogens of humans require molecular oxygen for several essential biochemical reactions, yet virtually
nothing is known about how they adapt to the relatively hypoxic environment of infected tissues. We isolated mutants
defective in growth under hypoxic conditions, but normal for growth in normoxic conditions, in Cryptococcus
neoformans, the most common cause of fungal meningitis. Two regulatory pathways were identified: one homologous
to the mammalian sterol-response element binding protein (SREBP) cholesterol biosynthesis regulatory pathway, and
the other a two-component-like pathway involving a fungal-specific hybrid histidine kinase family member, Tco1. We
show that cleavage of the SREBP precursor homolog Sre1—which is predicted to release its DNA-binding domain from
the membrane—occurs in response to hypoxia, and that Sre1 is required for hypoxic induction of genes encoding for
oxygen-dependent enzymes involved in ergosterol synthesis. Importantly, mutants in either the SREBP pathway or the
Tco1 pathway display defects in their ability to proliferate in host tissues and to cause disease in infected mice, linking
for the first time to our knowledge hypoxic adaptation and pathogenesis by a eukaryotic aerobe. SREBP pathway
mutants were found to be a hundred times more sensitive than wild-type to fluconazole, a widely used antifungal
agent that inhibits ergosterol synthesis, suggesting that inhibitors of SREBP processing could substantially enhance
the potency of current therapies.
Citation: Chun CD, Liu OW, Madhani HD (2007) A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen
Cryptococcus neoformans. PLoS Pathog 3(2): e22. doi:10.1371/journal.ppat.0030022
Introduction
Microbial pathogens must overcome numerous obstacles to
infection to successfully colonize a host. It has been
hypothesized that one of these barriers is hypoxia. Oxygen
levels in mammalian tissues are found to be considerably
below atmospheric levels [1–3]. Moreover, inflammation,
thrombosis, and necrosis associated with infection are
thought to lead to increased degrees of hypoxia [4,5]. While
many pathogenic microbes are facultative or obligate anae-
robes, a number of major bacterial and fungal pathogens are
classified as obligate aerobes. Among these are the bacterial
species Neisseria meningiditis, Pseudomonas aeruginosa, Mycobacte-
rium tuberculosis, and Bordetella pertussis. In N. meningitidis and B.
pertussis, mutants in homologs of the Escherichia coli hypoxia-
responsive regulator Fnr are attenuated in experimental
animals, consistent with a role for hypoxic adaptation in
virulence [6,7]. Microarray analysis indicates that in N.
meningitidis, Fnr activates genes encoding proteins involved
in sugar transport/utilization, cytochromes, and denitrifica-
tion enzymes that may promote usage of nitrate and nitrite
instead of oxygen as a terminal electron acceptor during
oxidative phosphorylation of ADP [6]. In contrast, a M.
tuberculosis mutant defective in a nitrate reductase required
for hypoxic growth in vitro was not attenuated in vivo [8].
In the fungal kingdom, some pathogens, such as Candida
albicans, are capable of anaerobic fermentation in rich
medium, but even in these species, molecular oxygen is
thought to be essential for synthesis of ergosterol, NAD, and
heme, molecules likely to be scarce in the host milleu and
therefore difficult to obtain. In bacterial pathogens, NAD and
heme synthesis can be catalyzed by alternative, oxygen-
independent pathways, and sterol synthesis is thought to
not exist [9,10]. Therefore, hypoxia should in principle be a
far more significant challenge for fungal than bacterial
pathogens; yet, it is unknown for any pathogenic fungi
whether adaptation to hypoxia is necessary for virulence, and
there is currently little information on the nature of
corresponding adaptive mechanisms. In the best-studied
human pathogenic fungus, C. albicans, one adaptive mecha-
nism may involve the pleiotropic virulence regulator Efg1.
Efg1 was recently shown in hypoxia to promote the synthesis
of unsaturated fatty acids and to repress filamentous growth,
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whereas in normoxia, Efg1 promotes filamentation, activates
glycolytic gene expression, and represses genes whose
products promote oxidative metabolism [11,12].
Recent work in the nonpathogenic ascomycete fission yeast
Schizosaccharomyces pombe has shown that a pathway homolo-
gous to the mammalian sterol-response element binding
protein (SREBP) pathway is important for hypoxic adaptation
[13,14]. In the mammalian pathway, sterols negatively
regulate the release of a transcriptionally active, soluble
DNA-binding portion of the SREBP transmembrane precur-
sor protein through regulation of two proteolytic steps, one
lumenal and one intramembrane [15]. Proteins required for
cleavage of the mammalian SREBP precursor include SREBP
cleavage-activating protein (SCAP), Insig, Site-1-protease,
and Site-2-protease [15]. SCAP interacts with SREBP to
regulate its cleavage and contains a domain thought to
directly bind sterols, Insig negatively regulates SCAP, Site-1-
protease is a member of the Kex2 family of lumenal
proteases, and Site-2-protease is a metalloprotease respon-
sible for intramembrane cleavage of the precursor [15]. The S.
pombe SREBP-like pathway controls the expression of genes
involved in ergosterol synthesis, and the available evidence
suggests that hypoxia signals the SREBP-like pathway by
reducing sterol levels, which, in turn, promotes the process-
ing of the SREBP homolog, Sre1 [13,14].
One way of assessing whether a particular property of a
pathogen is involved in virulence is to identify mutants
defective in that property and then assess the pathogenicity
of that mutant in an animal model of infection. For example,
early work in C. albicans demonstrated that an engineered
nonfilamentous mutant displayed greatly reduced virulence,
providing initial evidence for a link between filamentous
growth and virulence [16].
We have used the genetically tractable haploid human
pathogenic yeast Cryptococcus neoformans to probe the role of
hypoxic adaptation in fungal virulence. C. neoformans is an
obligate aerobe that causes meningitis and other infections in
immunocompromised individuals [17]. It exists as four
distinct serotypes that are classified into three groups: C.
neoformans var grubii (serotype A), C. neoformans var gatii
(serotypes B and C), and C. neoformans var neoformans (serotype
D). Together, these groups are estimated to cause between
15% and 40% of the 3.1 million annual deaths of individuals
with HIV/AIDS; serotype A isolates are associated with the
vast majority of infections in patients both positive and
negative for HIV [18,19]. For the studies described below, we
used the clinical serotype A isolate, H99.
Results/Discussion
As part of an ongoing gene disruption project, we have
generated targeted knockouts of ;1,200 C. neoformans genes
(O. Liu, E. Chow, and H. Madhani, unpublished data). We
screened this collection for mutants that displayed sensitivity
to hypoxia, and we report here the characterization of four
genes required for hypoxic adaptation. Among these are
homologs of proteins that act in the mammalian SREBP
pathway. We identified hypoxia-sensitive mutants in crypto-
coccal homologs of SREBP, Site-2-protease, and SCAP, which
we respectively name Sre1, Stp1, and Scp1 (Figures 1 and 2A).
Significantly, the basic helix-loop-helix (bHLH) DNA-binding
domain of Sre1 contains a conserved tyrosine residue (Figure
2B) that is specific to the SREBP family of bHLH tran-
scription factors [20]. We generated two independent knock-
outs of the genes encoding Sre1 (sre1D-1 and sre1D-2), Stp1
(stp1D-1 and stp1D-2), and Scp1 (scp1D-1 and scp1D-2), and in
each case, independent disruptions produced a hypoxia-
sensitive phenotype (Figure 1). Re-introduction of SRE1 into
the sre1D-2 strain restored sensitivity to levels similar to that
of wild-type (Figure S1A).
As mentioned in the Introduction, it has been shown that
in S. pombe, homologs of SREBP and SCAP are critical for
survival under hypoxic conditions [13,14]. Our identification
of a similar role for these components in the basidiomycete C.
Figure 1. Mutants in SREBP Pathway and Tco1 Are Sensitive to Hypoxia
Growth in normoxic and hypoxic conditions. Cultures diluted to OD600nm
¼ 0.6 were diluted serially in 10-fold increments prior to being spotted
onto YPD plates. Plates were incubated in normoxic or hypoxic
(controlled atmosphere chamber; less than 0.2% oxygen) conditions in
the dark at 37 8C. Top and bottom panels are from the same plates,
middle panels are from plates grown under the same conditions. WT,
wild-type.
doi:10.1371/journal.ppat.0030022.g001
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Author Summary
Opportunistic environmental pathogens adapt to hostile conditions
within the host to cause disease. We describe two pathways in the
pathogenic fungus Cryptococcus neoformans that are both necessary
for adaptation to hypoxia and required for its virulence. One
pathway uses a pathway homologous to the mammalian sterol-
response element binding protein (SREBP) pathway to activate
genes involved in sterol biosynthesis in response to low oxygen
levels, while the other pathway involves the two-component hybrid
histidine kinase protein Tco1. Mutant strains containing deletions of
genes encoding components in either of these pathways were
found to be less virulent in experimental mouse models. This study
suggests that this pathogenic fungus experiences low levels of
oxygen in the mammalian host, and that adaptation to these
conditions is important for infection. Targeting components of the
hypoxia response could yield more effective treatments for C.
neoformans infections, which cause a large fraction of HIV/AIDS-
related deaths worldwide. Notably, we find that mutants in the
SREBP-like pathway are a hundred times more sensitive than wild-
type cells to the widely used antifungal drug fluconazole.
neoformans suggests broad conservation of this adaptive
mechanism across the fungal kingdom. Curiously, examina-
tion of available databases yielded no clear homolog of Site-2-
protease in the S. pombe genome sequence or in the genomes
of fungi other than C. neoformans, suggesting that either this
component of the SREBP pathway does not exist in those
species or has diverged to a point where it is no longer
recognizable. We were also unable to identify a homolog of
Insig in C. neoformans, yet a clear homolog exists in S. pombe
[14]. Finally, no ortholog of Site-1-protease is apparent in
either genome; this function may be carried out by homologs
of Kex2 present in each genome. Notably, the C. albicans
protein most similar to Sre1 is Cph2 (Figure 2B), a transcrip-
tional regulator previously shown to regulate hyphal develop-
ment [21]. Although Cph2 binds to DNA elements similar to
those bound by SREBP in mammalian cells [21], it is unclear
whether it functions in an SREBP-like pathway.
In addition to components of the Sre1 pathway, we
identified a hypoxia-sensitive mutant in Tco1, a member of
a highly conserved family of fungal-specific histidine kinases
(Figure 1). Tco1 has been shown previously to be required for
virulence, yet the basis for this requirement has not been
elucidated [22]. Paradoxically, Tco1 negatively regulates the
expression of a known virulence factor, melanin formation,
and, redundantly with Tco2, positively regulates the HOG
MAPK pathway, which is dispensable for virulence [22]. We
generated a second independent knockout of TCO1, which
confirmed the hypoxia sensitivity of this mutant. Re-
introduction of TCO1 into the tco1D-1 strain rescued its
hypoxia-sensitive phenotype (Figure S1A). Significantly, a
tco1D sre1D double knockout is more sensitive to hypoxia than
either single mutant, indicating that Tco1 functions in a
pathway parallel to the SREBP pathway (Figure 1).
Homologs of Tco1 with diverse functions have been
described in a number of ascomycete fungi (Figure 2C).
One of these, Drk1, has been recently shown in the human
fungal pathogen Blastomyces dermatiditis to be required for
temperature-regulated dimorphism and pathogenesis; its
potential role in hypoxic adaptation was not reported [23].
A close homolog of Drk1 exists in Histoplasma capsulatum that
is also involved in temperature-regulated dimorphism [23]. It
was proposed that Drk1 is a transmembrane sensor that
contains an N-terminal domain containing two transmem-
brane domains. However, analysis of Drk1 using the SMART
database (Figure 2C) indicates that, instead, it contains a
series of six tandem HAMP domains characteristic of the
Figure 2. Predicted Protein Domains for SREBP Pathway Component Orthologs and Tco1 Histidine Kinase Family Members
(A) Protein domains as predicted by SMART (http://smart.embl-heidelberg.de) for C. neoformans Sre1, Scp1, and Stp1. Transmembrane segments for
Sre1 were predicted using MEMSAT3 (http://bioinf.cs.ucl.ac.uk). Arrowhead indicates site of 33FLAG insertion into Sre1. bHLH, bHLH DNA-binding
domain; peptidase, peptidase M50 family domain.
(B) ClustalW sequence alignment between C. neoformans Sre1 and its orthologs in C. albicans, Ustilago maydis, S. pombe, and human (SREBP-1A),
depicting a portion of the predicted DNA-binding domain. All five contain a conserved tyrosine residue (indicated by asterisk) specific to the SREBP
family of bHLH transcription factors.
(C) Domains as predicted by SMART for Tco1 homologs. C. neoformans Tco1, and orthologs to Tco1 from B. dermatiditis, H. capsulatum, C. albicans, and
Neurospora crassa. HATPase, histidine kinase ATPase domain; HisKA, histidine kinase A domain; REC, cheY-like homologous receiver domain.
doi:10.1371/journal.ppat.0030022.g002
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fungal-specific subfamily of histidine kinases, and is therefore
more likely to be a soluble signaling protein. HAMP domains
are found in a large number of signaling proteins, and, in one
of these proteins, forms a four-helix bundle that may
transduce signals via rotation of the helices [24]. In contrast
to dimorphic fungi such as B. dermatiditis, Coccidioides immitis,
and H. capsulatum, C. neoformans grows as a yeast both in the
environment and in the host, suggesting a distinct role in
virulence for Tco1 compared with that of its ascomycete
orthologs.
As with mutants in the Sre1 pathway, cells lacking Tco1
grow normally at 37 8C in minimal (yeast nitrogen base
[YNB]) or rich (yeast extract peptone dextrose [YPD])
medium under normoxic conditions, suggesting that their
defects in virulence are not due to a general growth defect
(Figure 3A). We examined two characteristics believed to be
important for virulence in C. neoformans, its polysaccharide
capsule and its ability to melanize. We observed no gross
defect in the formation of the polysaccharide capsule in any
of the mutants; however, quantification of the ratios of
capsule diameters to cell diameters did reveal rather subtle
defects in the sre1D and tco1D mutants (Figure 3B). Mutants in
the SREBP pathway display a slight defect in melanization
under normoxic conditions and, as previously reported,
mutants in TCO1 display hypermelanization (Figure 3C). A
tco1D sre1D double knockout also displays a slight defect in
melanization. The complemented strains sre1D-2þ SRE1 and
Figure 3. Phenotypic Characterization of Mutants in the SREBP Pathway and in TCO1
(A) Growth in YNB medium at 37 8C. Growth was monitored via OD600 measurements. Data shown are an average of three independent cultures for
each strain, and error bars represent standard deviations (SD).
(B) Capsule assays. Above, capsule synthesis was induced in wild-type (WT), sre1D-1, and tco1D-1 strains, and subsequently visualized using India ink
staining. Images were taken at 1603magnification. Below, quantification of the ratio of capsule diameter to cell diameter for capsule-induced cells from
the indicated strains. Data shown represent the mean 6 SD, n  30. p-Values (asterisks) were derived using Student’s t-test.
(C) Melanin assays. The indicated strains were grown to saturation and spotted onto L-DOPA–containing medium. The plates were then cultured at 37
8C in the dark.
doi:10.1371/journal.ppat.0030022.g003
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tco1D-1 þ TCO1 displayed wild-type levels of melanization
(Figure S1B).
In fission yeast, processing of Sre1 occurs in response to
hypoxia [14]. To test whether this was the case in C. neoformans,
we used homologous recombination to precisely insert three
tandem copies of the FLAG epitope tag into the Sre1 coding
sequence upstream of the predicted DNA-binding domain
(Figure 2A). We assessed the processing of the protein by
immunoblotting SDS-PAGE–fractionated extracts that were
prepared from cells grown under normoxic versus hypoxic
conditions (Figure 4). In response to hypoxia, a lower
molecular weight form of Sre1 could be detected.
In mammalian cells, cleavage releases SREBP from endo-
plasmic reticulum and Golgi membranes, allowing it to then
enter the nucleus and induce transcription of genes. It
therefore seemed likely that hypoxia-dependent cleavage of
Sre1 in C. neoformans would correlate with the up-regulation
of hypoxia-regulated genes.
To test this hypothesis, we used whole-genome microarray-
based transcriptional profiling. We found that that the
response of wild-type cells to hypoxic conditions involved
changes in the levels of 347 transcripts. These included the
up-regulation of homologs of genes involved in stress and
carbohydrate uptake/metabolism, similar to what has pre-
viously been reported in Saccharomyces cerevisiae [25], S. pombe
[13], and C. albicans [11]. Select categories are presented in
Table 1, and the full dataset is available in Table S3. In S.
cerevisiae, S. pombe, and C. albicans, genes encoding respiratory
proteins are down-regulated in response to hypoxia. In
contrast, in C. neoformans, these genes are up-regulated,
perhaps because it is an obligate aerobe. Similar to what
has been described in other fungi, transcripts of genes
involved in sterol, heme, and fatty acid metabolism are also
up-regulated in C. neoformans in response to low oxygen
conditions, including SRE1 and homologs to the genes ERG1,
ERG3, ERG5, ERG25, HEM3, HEM13, SCS7, SUR2, and OLE1.
Categories of genes down-regulated in response to hypoxia
include proteins involved in translation, vesicle trafficking,
and cell wall and capsule synthesis (CAP64 and CAP60).
A comparison in expression levels between wild-type and
sre1D-2 grown under normoxic conditions identified only two
genes as having significant differences in expression between
the two strains: SRE1 itself and ERG5, a C-22 sterol desaturase
involved in sterol synthesis (Table S5). While ERG5 requires
Sre1 for full expression under normoxic conditions, it does
not require Sre1 for its induction under hypoxic treatment
(Figure 5B).
We determined that of the 347 genes that were induced or
repressed in wild-type by hypoxic treatment, 54 required
Sre1 for their induction or repression (Table S4, summarized
in Figure 5A). Of the subset denoting hypoxia-induced genes
with weaker induction in sre1D-1 than in wild-type, the
greatest difference in expression between wild-type and
mutant were in the two genes ERG1 and ERG3. Strikingly,
these genes encode for homologs to oxygen-dependent
ergosterol biosynthetic pathway enzymes: ERG1 encodes
squalene epoxidase and ERG3 encodes C-5 sterol desaturase.
Both of these enzymes require molecular oxygen for their
catalytic activities. We confirmed these data using reverse
transcription quantitative PCR (RT-QPCR) analysis (Figure
5B).
We also performed similar experiments in strains lacking
Tco1. In contrast to mutants in Sre1, the tco1Dmutant did not
show detectable defects in the regulation of mRNA levels for
any of the 347 hypoxia-responsive genes (unpublished data).
Thus, this kinase appears to function independently of
transcription to mediate hypoxic adaptation, and we spec-
ulate that it may act post-transcriptionally. The phenotype of
tco1D is specific in that strains containing disruptions of the
other five histidine kinases encoded by the C. neoformans
genome do not demonstrate sensitivity to hypoxia (C. Chun,
unpublished observations).
Having identified mutants in two apparently distinct
regulatory pathways required for hypoxic adaptation, we
tested their effects on growth and virulence in infected
experimental mice. To assess the effects on proliferation and
survival in the host, we infected mice with 1:1 mixtures of
wild-type and mutant cells and examined their relative
representations in various tissues after a fixed period of
time. Two infection routes were tested, intravenous and
intranasal.
In the intravenous competition experiments, animals were
sacrificed 10 d post-infection and the proportions of mutant
cells in the lungs, brains, and spleens were determined. As
shown in Figure 6A, knockout mutants in SRE1, SCP1, STP1,
and TCO1 showed a dramatic and reproducible defect in their
ability to proliferate in lungs relative to wild-type cells. While
they represented ;50% of the cells in the inoculum, the
mutant cells made up only ;5% of the cells recovered from
the lungs. A more moderate and variable defect was observed
in the brains and spleens. As a control, we co-infected wild-
Figure 4. FLAG-Sre1 Is Processed in Low Oxygen Conditions
Proteins extracts from wild-type and two independent cultures of FLAG-
SRE1 grown in normoxic and hypoxic (bubbling mixed gas into flasks;
0.2% oxygen) conditions were fractionated by SDS-PAGE and immuno-
blotted with antibodies against the FLAG epitope. Immunoblotting with
antibodies against the cyclin-dependent protein kinase PSTAIRE was
used to control for variation in loading.
doi:10.1371/journal.ppat.0030022.g004
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type with a knockout mutant in SXI1, a gene involved in cell
identity and sexual differentiation that is not expressed in
non-mating cells and is dispensable for virulence [26,27]. In
these control experiments, sxi1D represented ;50% of the
cells in the inoculum and ;50% of the cells recovered from
the various tissues.
In the intranasal competition experiments, animals were
sacrificed 21 d post-infection and the proportion of mutant
cells in the lungs was determined. Again, knockout mutants in
SRE1, SCP1, STP1, and TCO1 showed a significant and
reproducible defect in their ability to proliferate in the lungs
relative to wild-type cells (Figure 6B). A control infection
using a 1:1 mixture of wild-type and sxi1D showed equal
proliferation between wild-type and mutant. We also per-
formed a co-infection using a mixture of wild-type and a
knockout mutant in LAC1, which encodes for the laccase
primarily responsible for melanin synthesis (Figure 6B). As
previously reported, the lac1D mutant, which is completely
defective in melanization (Figure 3C), displayed normal
proliferation in the lungs [28].
A role for Tco1 in virulence was established previously
using an intranasal inoculation assay [22]. To assess the role of
SREBP pathway components in virulence, we inoculated eight
to ten animals per strain by tail vein injection with two
independently generated knockout mutants in SRE1, SCP1,
and STP1, and monitored the mice for progression to severe
morbidity. As shown in Figure 6C, each of the mutants
displayed a similar and significant decrease in virulence.
Thus, like the Tco1 pathway, the SREBP pathway plays a
demonstrable role in pathogenesis.
Azole antifungals are perhaps the most widely used agents
for the treatment of fungal infections worldwide. They are
thought to act solely as inhibitors of lanosterol-14a-deme-
thylase, encoded in S. cerevisiae by ERG11, another oxygen-
dependent enzyme in the ergosterol biosynthetic pathway.
Our microarray analysis suggested a role for Sre1 in
activating transcription of genes encoding several oxygen-
dependent enzymes of this pathway, whereas Tco1 was
dispensable. If these effects were relevant to growth, mutants
in the Sre1 pathway should be sensitive to fluconazole
treatment. Indeed, we found that mutation of SRE1, STP1,
or SCP1 results in a dramatic increase in sensitivity to
fluconazole under normoxic conditions: ;1003 lower con-
centrations of fluconazole were required to inhibit their
Figure 5. Microarray Hybridization and RT-QPCR Studies Demonstrate That a Subset of Genes Involved in the Hypoxia Response Require Sre1 for Their
Regulation
(A) Summary of profiling transcriptional response to hypoxia in sre1D and wild-type (WT) cells. cDNA from wild-type cells cultivated in normoxic
conditions was hybridized against cDNA from wild-type cells exposed to hypoxic conditions on arrays containing 6,846 features from the genome of C.
neoformans. Similarly, cDNA from sre1D-1 grown in normoxia was hybridized against cDNA from sre1D-1 grown in hypoxia. Statistical analysis of the
resulting arrays was conducted using the software SAM. The transcriptional response to hypoxia in wild-type was identified as the set of genes with
statistically significant changes in gene expression as determined by SAM. A cutoff of 2-fold or greater changes in gene expression was imposed upon
this gene set to determine the number of genes up- and down-regulated in wild-type in response to hypoxia. The arrays hybridized with cDNA from
sre1D-1 were compared to those hybridized with wild-type cDNA to determine which hypoxia-induced transcriptional changes were significantly
different between sre1D-1 and wild-type. The resulting gene set is summarized above, where relative degree of induction/repression in sre1D-1 and
wild-type were compared by dividing fold-change in expression in sre1D-1 with fold-change in expression in wild-type.
(B) RT-QPCR. cDNA from sre1D-1 and wild-type cells grown in normoxia and hypoxia were amplified using primers against ERG1, ERG3, ERG5, and ACT1.
Values obtained for ERG1, ERG3, and ERG5 were normalized against ACT1 for each sample to give relative expression, and then expression for the three
genes were normalized to their expression in wild-type in normoxic conditions. Error bars represent standard deviation across four samples.
doi:10.1371/journal.ppat.0030022.g005
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growth compared with concentrations required for wild-type
growth inhibition (Figure 7). In contrast, a knockout mutant
of TCO1 displayed a sensitivity that was identical to that of
wild-type.
Fungal pathogens require molecular oxygen for the biosyn-
thesis of several molecules, making hypoxic host tissues an
inhospitable environment. Using the obligate aerobic human
pathogen C. neoformans as a model, we have identified two
pathways that are required for hypoxic adaptation and
virulence. We show that an SREBP-like pathway in C.
neoformans is activated by hypoxia, is required for hypoxic
adaptation, and controls the expression of oxygen-dependent
enzymes in the ergosterol biosynthetic pathway. The Sre1
pathway acts in parallel with a pathway controlled by the
histidine kinase homolog Tco1 in hypoxic adaptation.
Importantly, analysis of mutants clearly demonstrates both
are required for pathogen growth/survival in experimental
animals and for virulence, which strongly suggests a link
between hypoxic adaptation and pathogenesis. The simplest
interpretation of our data is that the pathogen experiences
hypoxia in the host to which it must adapt in order to cause
disease.
Other pathways are also likely to play a role in hypoxic
adaptation. For example, transcription of OLE1, which
encodes for a D9-fatty acid desaturase in S. cerevisiae, is
regulated in a manner that shows remarkable parallels to the
Sre1 pathway. In response to low levels of oxygen or
unsaturated fatty acids, a proteolytic cleavage event releases
the putative transcription factor Mga2 from the endoplasmic
reticulum membrane, allowing up-regulation of OLE1 tran-
scription [29]. Indeed, our microarray data shows that OLE1 is
Figure 6. Hypoxia-Sensitive Mutants Display Proliferation and Virulence
Defects
(A) Tail vein inoculation competition experiments. Approximately 1:1
mixtures of wild-type (WT) and the indicated mutant (marked with a NAT
resistance gene) were injected into mice (A/J) intravenously via the tail
vein (23 106 total cells/mouse). The actual proportion of mutant cells in
each inoculum were determined by plating a dilution of the inoculum on
nonselective medium and then assaying 100–200 individual colonies for
NAT resistance. At 10 d post-infection, animals were sacrificed and the
lungs, brains, and spleen from each animal were homogenized and serial
dilutions were plated. Then, 100–200 colonies per organ were assayed
for NAT resistance to determine the percentage of mutant cells. Error
bars represent the standard deviation from four mice per inoculum.
(B) Intranasal inoculation competition experiments. Approximately 1:1
mixtures of wild-type and the indicated mutant were inoculated
intranasally into mice (A/J) (5 3 105 total cells/mouse). The actual
proportions of mutant cells were determined as in (A). At 21 d post-
infection, animals were sacrificed and the lungs from each animal were
treated as in (A). Error bars represent the standard deviation from four
mice per inoculum.
(C) Virulence assays. Eight to ten mice (A/J) were injected intravenously
via the tail vein with 23 105 cells of the indicated strain and progression
to severe morbidity was monitored.
doi:10.1371/journal.ppat.0030022.g006
Figure 7. Mutants in the SREBP Pathway, but Not the tco1D Mutant,
Display Hypersensitivity to Fluconazole
Cells (104 cells/ml) of wild-type and each mutant strain were cultured in
YNB for three d in 96-well format in the presence of 0.0045–30 lg/ml
fluconazole, after which relative growth was assessed using OD600
measurements. Data shown are an average of at least three independent
cultures for each strain. Error bars represent standard deviations.
doi:10.1371/journal.ppat.0030022.g007
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up-regulated in C. neoformans in response to hypoxia in an
Sre1-independent manner.
Although our results show that hypoxia-sensitive mutants
in two distinct pathways are defective in virulence, it is
conceivable that the dual requirement for the Sre1 and Tco1
pathways in virulence reflects defects other than hypoxic
adaptation in the corresponding mutants. However, our data
argue that the requirement for these pathways cannot be
explained by a trivial defect for either pathway for growth in
minimal medium at 37 8C (Figure 3A). Furthermore, the
mutants do not display gross defects in capsule formation,
and they display phenotypes during murine infection distinct
from those defective in the production of two other virulence
factors, melanin and urease [28,30]. Specifically, while SREBP
pathway mutants display a slight defect in melanin formation,
their reduced growth in the lungs of mice infected intra-
nasally contrasts to that of lac1D mutants, which are
completely defective in melanization yet display normal
proliferation in the lungs both in published work [28] and
in our hands (Figure 6B). Likewise, mutants defective in
urease activity have been reported to not display a defect in
proliferation in the lungs [30], in contrast to the effects of
sre1D and tco1D mutants reported here. While distinct from
mutants defective in melanin and urease production, the
tissue proliferation/survival profiles of SREBP and Tco1
pathway mutants are similar to each other (Figure 6),
consistent with a common mechanism underlying their
virulence defects.
For each mutant strain tested, we observed a greater fold-
defect in the lungs compared with that in the brain or spleen.
At least two explanations could account for these observa-
tions. First, the hypoxic conditions within the lungs could be
more severe than in the brain or spleen, perhaps due to the
fact that the lungs are a predominant site of inflammation.
The influx of large numbers of activated macrophages into
the lungs may generate a locally hypoxic microenvironment
that is more challenging than those of the brain or spleen.
Alternatively, turnover rate of C. neoformans may be greater in
the lungs than in the brain and spleen, which would amplify
any per-division growth differences between wild-type and
mutant strains. Assuming similar steady-state levels of
organisms, higher turnover would require both a higher
growth rate of C. neoformans in the lungs as well as a greater
degree of killing than in the non-lung tissues. Further studies
will be required to distinguish between these possibilities.
The remarkable sensitivity of Sre1 pathway mutants to
fluconazole is relevant for two reasons. First, it suggests that
the effectiveness of antifungals that target ergosterol biosyn-
thesis may in part be aided in vivo by the sensitivity of
ergosterol synthesis to hypoxic conditions. This model may
explain observations in otherwise puzzling reports showing
that while fluconazole blood levels typically only reach 10–20
lg/ml, successful treatment of C. albicans isolates that display
in vitro resistance towards fluconazole (MIC . 50 lg/ml) can
be achieved in a substantial fraction of cases [31]. It may be
that hypoxic conditions in vivo lower the effective concen-
tration of the drug required to clear the infection. Second,
our data suggest that if inhibitors of the Sre1 pathway could
be developed, they would strongly synergize with ergosterol
pathway inhibitors such as azoles in the treatment of
cryptococcal infections.
Materials and Methods
Strains and media. C. neoformans serotype A strain H99 (a kind gift
of J. K. Lodge) was used as wild-type. Strains were grown in rich
medium, YPD (1% yeast extract, 2% Bacto-peptone, 2% glucose,
0.015% L-tryptophan, 0.004% adenine) or minimal medium, YNB
(0.45% yeast nitrogen base w/o amino acids w/o ammonium sulfate,
1.5% ammonium sulfate, 2% glucose). The strains used in this study
are listed in Table S1.
Strain engineering. The wild-type H99 strain was transformed
using biolistic techniques as previously described [32]. The gene-
specific deletion constructs were generated with the primers listed in
Table S2 using overlap fusion PCR. Specifically, the nourseothricin
(NAT) resistance (natR) cassette was amplified from plasmids derived
from pHL001 using the primers 59NAT-10 and 39NAT-10. This
cassette was targeted to delete specific genes by fusing the cassette to
the genomic sequences flanking the target gene. These flanking
sequences were amplified from H99 genomic DNA by PCR using the
***-W1 and ***-W3 primers to amplify a ;1-kb region 59 to the
target gene and the ***-W4 and ***-W6 primers to amplify a ;1-kb
region 39 to the target gene. The two flanking regions and the natR
cassette were fused into one product using PCR and biolistically
transformed. Transformants were selected on YPD agar plates
containing 100 lg/ml NAT. sre1D-1 was generated using the CN4363
set of primers and deletes a portion of SRE1, including the DNA-
binding domain. sre1D-2 was generated using the CDS_5817 set of
primers and deletes all of SRE1. scp1D-1 was generated using the
CN1329 set of primers and deletes a portion of SCP1 that includes
transmembrane domains. scp1D-2 was generated using the CDS_2788
set of primers and deletes all of SCP1. stp1D-1 and stp1D-2 were both
generated using the CDS_3547 set of primers, which deletes all of
STP1. stp1D-1 and stp1D-2 were independently generated in separate
biolistic transformations. tco1D-1 was generated using the CN1538 set
of primers and deletes all but ;200 bp at the 59 end of the open
reading frame (ORF). tco1D-2 was generated using the CDS_3015 set
of primers and deletes all of TCO1. sxi1D was generated using the
CN5693 set of primers and lac1D was generated using the CN2897 set
of primers. Both of these deletions result in a complete deletion of
the gene. Strains referred to as complete deletions may leave intact
small portions of the 59 or 39 ends of the ORF due to ambiguities in
the annotation, but are not likely to retain any function. The
recombination events were verified by PCR using the ***-V5 and
VER-5-3 primers to detect the 59 integration event and the ***-V3
and VER-3-2 primers to detect the 39 integration event. The
tco1Dsre1D double mutant was generated by using a neomycin
(NEO) resistance (neoR) cassette which was amplified from the
plasmid pJAF1 using the primers 59NAT-10 and 39NEO-10. The neoR
cassette was fused to flanks generated using the CDS_5817 set of
primers. This knockout construct was then transformed into the
tco1D-1 strain. Transformants were selected on YPD agar plates
containing 200 lg/ml G418.
As a redundant test to confirm the phenotypes of independent
disruptants, the sre1D-2 and tco1D-1 mutants were complemented by
biolistically transforming the knockout strains with two linear DNA
constructs simultaneously. The first construct restored SRE1 or TCO1
to its original locus, replacing the natR cassette which had been used
to disrupt the gene. The second construct inserted a neoR cassette
;300 bp upstream of the start of the SRE1 ORF, or ;1,100 bp
upstream of the start of the TCO1 ORF. Specifically, in order to
complement sre1D-2, the primers CDS_5817-W1 and CDS_5817-W6
were used to amplify the SRE1 ORF from H99 genomic DNA,
including 1 kb of upstream and downstream sequence, creating the
first transformation construct. The second transformation construct
was generated using overlap fusion PCR. The primers C_p5817-W1h
and C_p5817-W3 were used to generate the ;1-kb region down-
stream of the neoR insertion site, and the primers C_CPR202-W4
and C_CPR202-3F were used to amplify the ;1-kb region upstream
of the neoR insertion site. These two flanking regions were fused to
the neoR cassette, which was amplified as above, creating the second
transformation construct. In order to complement tco1D-1, the
primers CDS_3015-W1 and CDS_3015-W6 were used to amplify
the TCO1 ORF from H99 genomic DNA, including 1 kb of upstream
and downstream sequence, creating the first transformation con-
struct. The second transformation construct was generated using
overlap fusion PCR. The primers C_p3015-W1 and C_p3015-W3
were used to generate the ;1-kb region downstream of the neoR
insertion site, and the primers C_p3015-W4 and C_p3015-W6 were
used to amplify the ;1-kb region upstream of the neoR insertion site.
These two flanking regions were fused to the neoR cassette, creating
the second transformation construct. sre1D-2 and tco1D-1 were
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biolistically transformed with both constructs simultaneously, and
transformants were selected on YPD agar plates containing 200 lg/ml
G418. Positive transformants were patched onto YPD agar plates
containing 200 lg/ml G418 and then replica-plated onto YPD agar
plates containing 100 lg/ml NAT. Colonies that were resistant to
G418 and sensitive to NAT were screened using PCR for the presence
of the complete SRE1 or TCO1 ORF. The phenotypes of comple-
mented strains are shown in Figure S1.
Generation of the 33FLAG-tagged SRE1 strain. Three copies of the
FLAG epitope plus linker sequence (REQKLEL-33FLAG-GSGSGS)
were inserted between A313 and A314 of Sre1 just upstream of the
predicted DNA-binding domain. Insertion of the 33FLAG construct
was performed by biolistically transforming H99 with two linear DNA
constructs simultaneously. The first construct targeted the natR
cassette for insertion;300 bp upstream of the start of the SRE1ORF,
just downstream of the adjacent gene. The second construct targeted
the 33FLAG sequence for insertion into the SRE1 ORF but did not
contain any resistance marker. Both constructs were generated using
overlap fusion PCR. Specifically, the natR cassette was amplified as
described above. The primers C_5817-W1FLg and C_5817-W3 were
used to amplify the ;1,300-bp region between the site of insertion of
the natR cassette and the site of insertion for the 33FLAG sequence.
The primers C_CPR202-W4 and C_CPR202-3F were used to
amplify the ;1-kb region upstream of the natR insertion site. These
two flanking regions were fused to the natR cassette using overlap
PCR to create one of the two transformation constructs. The 33FLAG
sequence was amplified by PCR from the p3FLAG-KanMX [33]
plasmid using the primers C_5817-FLAGFg and C_5817-FLAGRg.
C_5817-W1Flg and C_5817-W3 were again used to amplify the
upstream flanking region between the 33FLAG insertion site and the
natR insertion site, and the primers C_5817–5FgFl and C_5817–5Re
were used to amplify the ;1-kb region downstream of the 33FLAG
insertion site. These two flanks were fused to the 33FLAG cassette
using overlap PCR to create the second transformation construct.
After biolistic transformation with both constructs simultaneously
and selection for NAT resistance, transformants were screened for
insertion of the 33FLAG sequence by PCR using the primers
C_5817V5Fle and C_5817-FLAGFg.
Hypoxic cultivation. Strains were grown in YPD at 37 8C. Normoxic
conditions were considered general atmospheric levels within the lab
(;21% O2). For hypoxic conditions, two systems were employed. One
system consisted of a controlled atmosphere chamber (855-AC; Plas-
Labs, http://www.plas-labs.com) maintained at 37 8C and kept at below
0.2% oxygen levels utilizing a gas mixture containing 5% CO2, 10%
H2, 85% N2 in combination with palladium catalyst. While the
hydrogen–palladium mixture eliminated most oxygen within the
chamber, the architecture of the chamber did allow a small amount of
oxygen to slowly enter the chamber, allowing for C. neoformans
cultivation (as it is an obligate aerobe). Oxygen levels within the
controlled atmosphere chamber were monitored using a QRAE Plus
oxygen detector (RAE Systems, http://www.raesystems.com). Low
oxygen (and not high CO2) was the most likely source of the
phenotypes presented in this paper, as all strains grew normally in
atmospheric conditions that were supplemented with 5% CO2
(Figure S2). The second system utilized a gas mixture containing
0.2% O2, 0.25% CO2, 99.55% N2 that was bubbled through sterile
pipettes into medium contained in silicon-stoppered flasks arranged
in parallel. The gas mixture was humidified prior to being bubbled
into the medium by first bubbling through sterile water to minimize
medium loss.
For growth plate phenotypes, cultures grown in YPD at 37 8C were
diluted to OD600 nm¼0.6 in water, then diluted 10-fold in series prior
to being spotted onto YPD agar plates. Plates were then cultured in
the dark in normoxic or in the controlled atmosphere chamber in
hypoxic conditions.
For the growth curve, cultures were grown overnight in liquid YNB
medium and diluted to OD600 nm ¼ 0.085 in YNB. These were then
cultured at 37 8C in a roller drum. At the indicated time intervals, cell
density was assessed via OD600 readings. Data shown are an average of
three independent experiments and error bars represent their
standard deviations.
Capsule assay. C. neoformans strains were grown in liquid YPD
cultures overnight at 30 8C. The cultures were then diluted 1/100 in
either Sabouraud medium (non-inducing conditions) or 10%
Sabouraud medium buffered to pH 7.3 with 50 mM MOPS
(capsule-inducing conditions) and grown at 30 8C for 3 d. An equal
volume of culture and India ink were mixed and the capsule was
visualized using bright-field microscopy at 1603magnification using
an Axiovert 200M (Zeiss, http://www.zeiss.com) microscope running
Axiovision software. To quantitate capsule size, the cell diameter and
capsule diameter of at least 30 cells per strain under capsule-inducing
conditions were measured using the Axiovision software. Statistical
analysis was by Student’s t-test.
Melanization assays. Cultures grown overnight in YPD medium
were spotted onto melanin-inducing plates containing L-DOPA (L-
dihydroxyphenylalanine, 100 mg/l; Sigma, http://www.sigmaaldrich.
com) and grown for 3–5 d in the dark at 37 8C.
Isolation of total RNA. Log-phase cultures were grown aerobically
in YPD at 37 8C, with shaking, to an OD600 nm¼0.6, at which point the
cultures were split into two. For hypoxic growth, cells were collected
by centrifugation and then resuspended while in the controlled
atmosphere chamber with 50 ml of YPD medium that had been
previously deoxygenated by .2 h incubation with agitation in
chamber. For normoxic growth, cultures were maintained in
atmospheric conditions. Following 2 h of hypoxic treatment, both
normoxic and hypoxic cultures were collected by centrifugation at 4
8C. Cell pellets were flash frozen in liquid nitrogen and lyophilized
prior to total RNA extraction using TRIzol Reagent (Invitrogen,
http://www.invitrogen.com) following manufacturer’s instructions.
RNA samples were treated with DNase I (Roche, http://www.roche.
com) for 30 min at 37 8C, followed by two extractions with
chloroform, precipitation in isopropanol, and resuspension in
DEPC-treated water.
Microarray-based genome-wide transcriptional profiling. Total
RNA was reverse transcribed by priming with oligo dT and utilizing
aminoallyl-dUTP. The resultant cDNA was then coupled to Cy3- and
Cy5-labeled probes (Amersham Biosciences, http://www.amersham
biosciences.com), and hybridized to microarrays printed on site,
containing 6,846 70-mer oligonucleotides corresponding to C. neofor-
mans ORFs from the serotype A genome as annotated by our
laboratory (http://cryptogenome.ucsf.edu). Labeled cDNA from wild-
type grown in normoxic conditions was hybridized against cDNA
from wild-type grown in hypoxic conditions; cDNA from sre1D-1
grown in normoxia was hybridized against sre1D-1 grown in hypoxia;
cDNA from tco1D-1 grown in normoxia was hybridized against tco1D-1
grown in hypoxia; and cDNA from sre1D-2 grown in normoxia was
hybridized against wild-type grown in normoxia. Data for each strain
represents four independent experiments and includes two dye-
swaps. Arrays were scanned on an Axon 400B scanner with GenePix
software (Axon Instruments, http://www.moleculardevices.com) and
the images generated were analyzed using SpotReader software (Niles
Scientific, http://www.nilesscientific.com) for spot identification and
flagging. Array signals were bulk-normalized and filtered for flagged
spots using NOMAD (available at http://ucsf-nomad.sourceforge.net).
Data were log-transformed (base 2) and filtered for genes that
contained data for at least three out of four arrays from each strain,
and missing values were calculated through K-nearest neighbor
algorithm using Significance Analysis of Microarrays (SAM) software
[34] prior to statistical analysis by SAM. The class of genes up- and
down-regulated in wild-type was determined in a one-class response
test based on the arrays hybridized with cDNA from wild-type. Genes
were defined as being significantly regulated in wild-type if they were
scored by SAM as significant with a median false discovery rate (FDR)
of less than 8% and if their expression changed by at least 2-fold or
greater. For comparison of the differences in transcriptional
response to hypoxia in wild-type and mutant, a two-class response
test was employed, comparing the arrays hybridized with wild-type
cDNA to either the sre1D-1 arrays or the tco1D-1 arrays. All SAM
analysis employed an FDR of less than 8%. The comparison between
wild-type and tco1D-1 arrays at this FDR did not return any genes with
statistically significant differences between the two strains. The data
from the set of genes returned from the comparison between wild-
type and sre1D-1 were averaged across the four arrays per strain, and
the average fold-change in expression in sre1D-1 was divided by the
average fold-change in expression in wild-type for each gene. For the
set of genes up-regulated by wild-type in response to hypoxia, if this
value was greater than 1, the gene was defined as having stronger
induction in sre1D-1 than in wild-type, whereas if the value was less
than 1, the gene was defined as having weaker induction in sre1D-1
than in wild-type. For the set of genes down-regulated by wild-type in
response to hypoxia, if this value was greater than 1, the gene was
defined as having weaker repression in sre1D-1 than in wild-type, and
if the value was less than 1, the gene was defined as having stronger
repression in sre1D-1 than in wild-type. Statistically significant genes
identified by SAM with 2-fold or greater changes in expression are
listed in Tables S3 and S4 in Supporting Information.
Gene naming conventions. We refer to the generic names
described by the Stanford B-3501 serotype D genome annotation.
These are in the form CNXY, where X indicates the chromosome (A
for Chromosome I, B for Chromosome II, etc.) and Y indicates the
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gene position. In addition, if a gene has a homolog in S. cerevisiae with
a BLASTP expect value of less than 104, we refer to it by the name of
the best S. cerevisiae homolog. In cases where the same gene in S.
cerevisiae was the closest homolog to multiple genes in C. neoformans,
two digits were added to the end of the S. cerevisiae name to generate
unique specific names (e.g., SPS1901 is one C. neoformans gene
homologous to the S. cerevisiae gene SPS19) (E.Chow, O. Liu, and S.
O’Brien, unpublished data).
RT-QPCR. Microarray results were confirmed utilizing RT-QPCR.
cDNA was synthesized from the same DNase I–treated total RNA that
was used for microarray analysis using Superscript III Reverse
Transcriptase (Invitrogen) and oligo dT primers. Approximately 0.2
ng of cDNA was used as template in a QPCR reaction containing
SYBR Green dye (Molecular Probes, http://probes.invitrogen.com).
Fluorescent signal was measured on an Opticon DNA Engine PCR
machine (MJ Research, http://www.bio-rad.com). For each primer set,
standard curves were generated using 5-fold sequential dilutions of
cDNA to account for differences in priming efficiencies. For each
sample, values obtained were normalized to the levels of actin (ACT1).
Data shown are averages of the four independent samples, and are
normalized to the levels of transcript present on average in wild-type
under normoxic conditions. The following primers were used: for
ERG1, C_ERG1-3-5 and C_ERG1-5-5; for ERG3, C_ERG3-3-5 and
C_ERG3-5-5; for ERG5, C_ERG5-3-1 and C_ERG5-5-1; for ACT1,
C_ACT1–1 and C_ACT1–2.
Immunoblotting. Strains containing FLAG-SRE1 as the sole allele
were grown to OD600 nm ¼ 0.4 in 100 ml YPD at 37 8C. For the
normoxic growth sample, half the culture was then harvested. For
hypoxic growth, the remaining culture was spun down and the cell
pellet was then resuspended in 50 ml YPD medium that had been
previously de-oxgenated for .2 h by the bubbling of gas (a mixture
containing 0.2% O2, 0.25% CO2, 99.55% N2) through sterile pipettes
into the medium contained in silicon stopper-sealed flasks. The
cultures were then cultivated in the presence of bubbling gas mixture
for an additional 2 h before harvesting. Both normoxic and hypoxic
cultures were pelleted by centrifugation, and following a wash with
cold water, were flash frozen in liquid nitrogen and lyophilized. The
lyophilized cells were lysed in 24 mM NaOH and 1% (v/v) b-
mercaptoethanol on ice for 30 min, and proteins were precipitated
with 6.4% trichloracetic acid while on ice. After centrifugation, the
protein pellet was washed once with acetone, dried, and then
resuspended in HU buffer (200 mM phosphate buffer [pH 6.8], 8M
urea, 5% SDS, 1 mM EDTA, 100 mM DTT, bromophenol blue) and
loaded onto a bis-Tris gel. Following SDS-PAGE, the fractionated
proteins were transferred to nitrocellulose membrane (MSI Nitro-
bind membrane; Fisher Scientific, https://www1.fishersci.com). Immu-
noblotting was performed using mouse anti-FLAG IgG (Sigma) and
rabbit anti-PSTAIRE IgG (Santa Cruz Biotechnology, http://
www.scbt.com), which were recognized by horseradish peroxidase-
conjugated goat anti-mouse IgG and goat anti-rabbit IgG secondary
antibodies (Bio-Rad, http://www.bio-rad.com), respectively. Visual-
ization was performed utilizing SuperSignal West Pico Chemilumi-
nescent Substrate (Pierce, http://www.piercenet.com).
Intravenous co-infection experiments. C. neoformans strains were
individually grown in liquid YPD cultures overnight at 30 8C. Cells
were counted using a hemacytometer and an equal number of wild-
type cells and cells of the co-infecting strain were combined. The cells
were washed twice in PBS and resuspended in PBS to a final
concentration of 2 3 107 cells/ml. Then, 5–6 wk-old female A/J
(National Cancer Institute [NCI]) mice were anesthetized with inhaled
isoflurane, and 100 ll of the inoculum (23106 total cells) was injected
via tail vein. Four mice were infected per inoculum. A dilution of
each inoculum was also plated on Sabouraud agar plates containing
40 lg/ml gentamicin and 50 lg/ml carbenicillin. The plates were
incubated for 2 d at 30 8C, colonies were counted to verify the
concentration of cells in the inoculum, and the proportion of mutant
cells in the inoculum was determined by assaying 100–200 colonies
for NAT resistance on YPD agar plates containing 100 lg/ml NAT.
Mice were sacrificed by CO2 inhalation followed by cervical
dislocation 10 d post-infection, and the lung, brain, and spleen were
removed and homogenized in 5 ml sterile PBS. Serial dilutions of
each organ sample were plated on Sabouraud agar plates containing
40 lg/ml gentamicin and 50 lg/ml carbenicillin. The plates were
incubated for 2 d at 30 8C, colonies were isolated, and the proportion
of mutant cells within each organ was determined by assaying 100–
200 colonies for NAT resistance on YPD agar plates containing 100
lg/ml NAT.
Intranasal co-infection experiments. Inocula were prepared as in
the intranvenous co-infection experiments except cells were resus-
pended inPBS to afinal concentration of 13107 cells/ml. Then, 4–5wk-
old female A/J (NCI) mice were anesthetized by intraperitoneal
injection of ketamine (75 mg/kg) and medetomidine (0.5–1.0 mg/kg).
Themicewere then suspended froma silk thread by their front incisors
and 50 ll of the inoculum (53105 cells) were slowly pipetted into the
nares. After 10 min, the mice were lowered and the anesthesia was
reversed by intraperitoneal injection of atiplamezole (1.0–2.5 mg/kg).
Four mice were infected per inoculum. The concentrations of the
inocula and the proportions of mutant cells in the inocula were
determined as in the intravenous co-infection experiments. After 21 d
post-infection, the animals were sacrificed by CO2 inhalation followed
by cervical dislocation and the lungs were analyzed as in the
intravenous co-infection experiments.
Mouse virulence studies. Inocula were prepared as in the
intravenous-co-infection experiments, except cells were resuspended
in PBS to a final concentration of 23106 cells/ml. Then, 5–6 week-old
female A/J (NCI) mice were anesthetized with inhaled isoflurane and
100 ll of the inoculum (23 105 cells) were injected via the tail vein.
The concentration of cells in the inoculum was confirmed by plating
serial dilutions. Mice were monitored several times a week until onset
of symptoms (weight loss, ruffled fur, abnormal gait) and then
monitored daily. Mice that displayed signs of severe morbidity
(weight loss, abnormal gait, hunched posture, swelling of the cranium)
were sacrificed by CO2 inhalation followed by cervical dislocation.
Fluconazole sensitivity assay. Strains were cultured overnight in
YNB medium at 30 8C, spun down, washed once in PBS, and then
resuspended in YNB to a concentration of 104 cells/ml. This
resuspension was aliquoted into 96–deep well plates at a volume of
500 ll/well. To this, 100 ll of fluconazole (Sigma; stock solution of 1
mg/ml prepared in dimethyl sulfoxide [DMSO] and subsequently
diluted in YNB) was added to give final fluconazole concentrations
ranging from 0.0046 to 30 lg/ml. The plates were cultured for 48 h at
30 8C with shaking (1,000 rpm), at which point measurements were
taken on a spectrophotometer. For each culture, 100 ll of YNB was
added to one well instead of fluconazole. The OD600 reading for this
well was set to a value of one, and growth in all other wells for that
culture were normalized to that reading. For each strain, appropriate
dilutions of DMSO without fluconazole were added to a series of
cultures as a negative control. Growth with DMSO for all strains at all
concentrations tested was similar to growth without DMSO (unpub-
lished data).
Supporting Information
Figure S1. Complementation of Hypoxia-Sensitivity and Melanization
Phenotypes sre1D and tco1D Strains by Homologous Targeting of the
Corresponding Wild-Type Genes
(A) SRE1 was re-introduced into its endogenous locus in sre1D-2 and
TCO1 was re-introduced into its endogenous locus in tco1D-1.
Cultures diluted to OD600nm ¼ 0.6 were diluted serially in 10-fold
increments prior to being spotted onto YPD plates. Plates were
incubated in normoxic or hypoxic (controlled atmosphere chamber;
less than 0.2% oxygen) conditions in the dark at 37 8C.
(B) Melanin assays. The indicated strains were grown to saturation
and spotted onto L-DOPA–containing medium. The plates were then
cultured at 37 8C in the dark.
Found at doi:10.1371/journal.ppat.0030022.sg001 (4.1 MB PDF).
Figure S2. Knockout Mutants in SREBP Pathway Components and in
TCO1 Are Not Sensitive to High Levels of Carbon Dioxide
Cultures diluted to OD600nm ¼ 0.6 were diluted serially in 10-fold
increments prior to being spotted onto YPD plates. Plates were
incubated in the dark at 37 8C in normal atmospheric conditions or
in air supplemented with 5% CO2 (NuAire IR Autoflow CO2 Water-
Jacketed Incubator, http://www.nuaire.com).
Found at doi:10.1371/journal.ppat.0030022.sg002 (7.9 MB PDF).
Table S1. Strains Used in This Study
Found at doi:10.1371/journal.ppat.0030022.st001 (38 KB DOC).
Table S2. Primers Used in This Study
Found at doi:10.1371/journal.ppat.0030022.st002 (114 KB DOC).
Table S3. Microarray Dataset
Found at doi:10.1371/journal.ppat.0030022.st003 (103 KB XLS).
Table S4. Sre1-Regulated Genes in Hypoxia
Found at doi:10.1371/journal.ppat.0030022.st004 (35 KB XLS).
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Table S5. Sre1-Regulated Genes in Normoxia
Found at doi:10.1371/journal.ppat.0030022.st005 (15 KB XLS).
Accession Numbers
Microarray data described in this paper has been submitted to the
National Center for Biotechnology Information (NCBI) Gene
Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo)
under accession number GSE6226. The GenBank (http://www.ncbi.
nlm.nih.gov/Genbank/index.html) accession number for the sequen-
ces discussed in this paper are as follows: Stanford B-3501 serotype D
genome (AAEY00000000); Sre1 homologs from C. albicans
(AAK69672), human (SREBP-1A, NP_001005291), S. pombe
(CAB52036), and Ustilago maydis (XP_761868); and Tco1 homologs
from B. dermatiditis (ABF13477), C. albicans (BAA24952), and Neurospora
crassa (AAB03698). Where GenBank accession numbers were not
available, we have provided annotation by the Broad Institute of MIT
and Harvard (http://www.broad.mit.edu): C. neoformans Scp1 (Broad
locus CNAG_01580.1), Sre1 (Broad locus CNAG_04804.1), Stp1
(Broad locus CNAG_05742.1) , and Tco1 (Broad locus
CNAG_01850.1); and H. capsulatum ortholog to Tco1 (Broad locus
HCAG_4501.1).
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